Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT07186699
Official study title

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Study summary

This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNon-Interventional Study

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 22, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?University of Southern California

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Southern California
Interventions being studied
Other: Non-Interventional Study
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type
Non-small cell lung cancer (NSCLC)→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • \
  • Adults ≥ 18 years of age
  • Histopathologic or cytologic diagnosis of thoracic cancers, including lung and esophageal
  • Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy)
  • Ability to understand and the willingness to sign a written informed consent
  • English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent
Reasons someone may not be able to joinExclusion criteria

Patients with cognitive disability unable to maintain 30-60 minute conversation

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Los Angeles General Medical CenterLos Angeles, California
  • USC / Norris Comprehensive Cancer CenterLos Angeles, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 22, 2026. Always confirm current availability with the study team.

View original record ↗